TARGIT-IORT during surgery is better for patients than standard radiotherapy for early breast cancer

See the Full paper at https://www.bmj.com/content/370/bmj.m... and academic video abstract at https://bcove.video/2DRjUvi Improving breast cancer treatment: Long-term results of the TARGIT-A randomised trial (www.targit.org.uk) of risk-adapted single-dose TARGIT-IORT given during lumpectomy for breast cancer vs whole breast radiotherapy given post-operatively by visiting the radiotherapy centre daily for 3 to 6 weeks. Slide credit - Jayant S Vaidya and Uma J Vaidya Funding - UK Department of Health - NIHR - HTA programme. Comment published in British Journal of Cancer https://doi.org/10.1038/s41416-020-01... PDF download is at https://rdcu.be/cfcrV Further analysis published in https://www.nature.com/articles/s4141... Worldwide adoption is described in https://www.frontiersin.org/articles/...